LD-2 disclosure · 3rd Quarter - Report
LIEBER INSTITUTE FOR BRAIN DEVELOPMENT
Client
- Description
- Developmental brain disorder research
- Location
- Maryland · United States of America
Registrant
- Description
- Law firm
- Location
- Washington, District of Columbia, United States of America
Lobbying activities
2 issuesBudget/Appropriations
Engagement on FY23 L-HHS Appropriations (H.R. 8295/S. 4659) Congressional Directed Spending requests related to diagnostic and drug discovery to improve health outcomes for African Americans, and engagement on FY24 appropriations requests related to furthering Liebers mission of understanding the genetic and molecular mechanisms behind schizophrenia and brain disorders to improve the lives of all individuals affected by such conditions.
LobbyistsEUGENIA PIERSON · CASEY BROUHARD · ms NATALIE TIETJEN · DOROTHY ISGUR · mr KEVIN MICHAEL O'NEILL
Covered position (ms NATALIE TIETJEN): Intern, Rep. Watson Coleman (2018)
TargetedSENATE · HOUSE OF REPRESENTATIVES
Medical/Disease Research/Clinical Labs
Engagement with the Department of Energy (DOE) relating to accessing the agency's supercomputers for the purpose of conducting research on brain disorders.
LobbyistsKRISTINE BLACKWOOD · EUGENIA PIERSON · CASEY BROUHARD · ms NATALIE TIETJEN · DOROTHY ISGUR · mr KEVIN MICHAEL O'NEILL
Covered position (ms NATALIE TIETJEN): Intern, Rep. Watson Coleman (2018)
TargetedEnergy, Dept of